期刊文献+

糖尿病患者外周血白细胞端粒酶活性变化及其影响因素分析 被引量:4

暂未订购
导出
摘要 目的观察糖尿病患者白细胞端粒酶活性变化,并分析外周血白细胞端粒酶活性的影响因素。方法以1型糖尿病(T1DM)患者40例为A组,2型糖尿病(T2DM)患者80例为B组,健康体检者50例为对照组。抽取各组外周静脉血5 m L,离心后提取白细胞,采用荧光定量PCR法检测各组白细胞中端粒酶活性。采用多元线性回归分析法分析T2DM患者白细胞中端粒酶活性的影响因素。结果 A、B、C组外周血白细胞端粒酶活性(Ct值)分别为31.64±1.03、32.22±0.75、33.19±0.95,组间两两比较,P均<0.05。性别、吸烟状况与T2DM患者外周血白细胞端粒酶活性有关(P均<0.05)。结论糖尿病患者外周血白细胞端粒酶活性升高,且T1DM患者白细胞端粒酶升高更明显。性别、吸烟状况是T2DM患者外周血白细胞端粒酶活性的影响因素。
出处 《山东医药》 CAS 北大核心 2016年第27期85-87,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81472744 81272444)
  • 相关文献

参考文献14

  • 1Zakian VA.Structure,function,and replication of Saccharomyces cerevisiae teleromes[J].Annu Rev Genet,1996,30(1):141-172.
  • 2Shay JW,Wright WE.Hallmarks of telomeres in ageing research[J].J Pathol,2007,211(2):114-123.
  • 3Fyhrquist F,Tiitu A,Saijonmaa O,et al.Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes[J].J Intern Med,2010,267(3):278-286.
  • 4Liu ZL,Zhang JH,Yan JT,et al.Leucocyte telomere shortening in relation to newly diagnosed type 2 diabetic patients with depression[J].Oxid Med Cell Longev,2014,2014:1-8.
  • 5程桦.糖尿病[M].7版.北京:人民卫生出版社,2009:365-371.
  • 6蒋玉艳,何敏,杨莉,李开鹏.荧光定量PCR法检测肿瘤细胞端粒酶活性的变化[J].现代生物医学进展,2006,6(7):12-16. 被引量:1
  • 7Wege H,Chui MS,Le HT,et al.SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity[J].Nucleic Acids Res,2003,31(2):E3.
  • 8刘莹,董成永,崔晓楠.人端粒酶逆转录酶肿瘤相关反馈调节机制的研究进展[J].大连医科大学学报,2015,37(6):605-609. 被引量:1
  • 9Chen W,Chen SM,Yu Y,et al.Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells[J].J Laryngol Otol,2010,124(7):780-783.
  • 10Hiyama K,Hirai Y,Kyoizumi S,et al.Activation of telomerase in human lymphocytes and hematopoictic progenitor cells[J].J Immunol,1995,155(8):3711.

二级参考文献54

  • 1岳志红,张正.端粒酶检测技术在肿瘤诊断中的应用[J].中华检验医学杂志,2004,27(7):476-478. 被引量:5
  • 2朱忠超,刘志苏,艾中立,顾潮江.表没食子儿茶素没食子酸酯诱导肝癌细胞凋亡并伴随端粒酶活性下调[J].武汉大学学报(医学版),2004,25(6):663-665. 被引量:5
  • 3Jeanclos E,Krolewski A,Skurnick J,et al.Shortened telomere length of WBC of patients with IDDM Diabetes[J].Diabetes,1998,47(3):482-486.
  • 4de Magalhaes JP.From cells to ageing:a review of models and mechanisms of cellular senescence and their impact on human ageing[J].Exp Cell Res,2004,300(1):1-10.
  • 5Moore JK,Gold DP,Dreskin SC,et al.A diabetogenic gene prevents T cells from receiving costimulatory signals[J].Cell Immunol,1999,194(1):90-97.
  • 6Hemandez-Hoyos G,Josephs S,Miller NG,et al.The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes[J].Eur J Immunol,1999,29(6):1832-1841.
  • 7Wojtyla A, Gladych M, Rubis B. Human telomerase activity regulation[J]. Mol Biol Rep, 2011, 38(5): 3339-3349.
  • 8Shay JW, Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer, 1997, 33(5): 787-791.
  • 9Zvereva MI, Shcherbakova DM, Dontsova OA. Telomerase: structure, functions, and activity regulation[J]. Biochemistry(Mosc), 2010, 75(13): 1563-1583.
  • 10Perrault SD, Hornsby PJ, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells[J]. Biochem Biophys Res Commun, 2005, 335(3): 925-936.

共引文献5

同被引文献55

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部